BRISTOL-MYERS SQUIBB COMPANY Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31)
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31) of $193.00 million for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-10-27.
Discontinued › Income Statement › Other Income
us-gaap:DeferredRevenueRevenueRecognized · last filed 2016-10-27
- BRISTOL-MYERS SQUIBB COMPANY deferred revenue, revenue recognized (deprecated 2016-01-31) for the quarter ending 2016-03-31 was $82.00M, a 1.23% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY deferred revenue, revenue recognized (deprecated 2016-01-31) for the quarter ending 2015-03-31 was $81.00M, a 1.25% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY deferred revenue, revenue recognized (deprecated 2016-01-31) for the quarter ending 2014-03-31 was $80.00M, a 27.93% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY deferred revenue, revenue recognized (deprecated 2016-01-31) for the quarter ending 2013-03-31 was $111.00M, a 136.17% increase year-over-year.
| Period end | Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31) 3 month | Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31) 6 month | Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31) 9 month |
|---|---|---|---|
| 2016-09-30 | $193.00M 10-Q · filed 2016-10-27 | ||
| 2016-06-30 | $143.00M 10-Q · filed 2016-07-28 | ||
| 2016-03-31 | $82.00M 10-Q · filed 2016-04-28 | ||
| 2015-09-30 | $233.00M 10-Q · filed 2016-10-27 | ||
| 2015-06-30 | $159.00M 10-Q · filed 2016-07-28 | ||
| 2015-03-31 | $81.00M 10-Q · filed 2016-04-28 | ||
| 2014-09-30 | $270.00M 10-Q · filed 2015-10-27 | ||
| 2014-06-30 | $174.00M 10-Q · filed 2015-07-23 | ||
| 2014-03-31 | $80.00M 10-Q · filed 2015-04-28 | ||
| 2013-09-30 | $398.00M 10-Q · filed 2014-10-24 | ||
| 2013-06-30 | $248.00M 10-Q · filed 2014-07-24 | ||
| 2013-03-31 | $111.00M 10-Q · filed 2014-04-29 | ||
| 2012-09-30 | $186.00M 10-Q · filed 2013-10-23 | ||
| 2012-06-30 | $91.00M 10-Q · filed 2013-07-25 | ||
| 2012-03-31 | $47.00M 10-Q · filed 2013-04-25 | ||
| 2011-09-30 | $112.00M 10-Q · filed 2012-10-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |